Recruitment completed for denovoSkin™ Phase 2 clinical trial in reconstructive surgery
Switzerland, 07 November – CUTISS AG, a Swiss clinical-stage life sciences company focused on skin regenerative medicine and tissue engineering, has announced the successful completion of patient recruitment for the Phase 2 clinical trial of its lead product, denovoSkin™, in reconstructive surgery for both children and adults. This Phase 2 clinical trial evaluates the safety […]
Recruitment completed for denovoSkin™ Phase 2 clinical trial in reconstructive surgery Read More »
